Were Hedge Funds Right About NGM Biopharmaceuticals, Inc. (NGM)?
In this article we will analyze whether NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead into their best ideas. While not all of these picks will be winners, our research shows that these picks historically outperformed the market by double digits annually.
Is
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) a superb investment today? The smart money was taking an optimistic view. The number of bullish hedge fund bets rose by 5 in recent months. NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) was in 18 hedge funds’ portfolios at the end of the first quarter of 2021. The all time high for this statistic was previously 13. This means the bullish number of hedge fund positions in th
Were Hedge Funds Right About Dumping Redfin Corporation (RDFN)?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter of 2021. One of these stocks was Redfin Corporation (NASDAQ:RDFN).
Is
Redfin Corporation (NASDAQ:RDFN) the right pick for your portfolio? Prominent investors were in a bearish mood. The number of bullish hedge fund bets fell by 3 recently. Redfin Corporation (NASDAQ:RDFN) was in 18 hedge funds’ portfolios at the end of the first quarter of 2021. The all time high for this statistic is 28. Our calculations also showed that RDFN isn’t among the 30 most popular stocks among hedge funds (click for Q1 rankings).
Were Hedge Funds Right About Repare Therapeutics Inc. (RPTX)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings disclosed the funds’ positions on March 31st. We at Insider Monkey have made an extensive database of more than 866 of those established hedge funds and famous value investors’ filings. In this article, we analyze how these elite funds and prominent investors traded Repare Therapeutics Inc. (NASDAQ:RPTX) based on those filings.
Hedge Funds Cashed Out Of AnaptysBio, Inc. (ANAB) Too Early
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as to maintain the desired risk profile. As a result, the relevancy of these public filings and their content is indisputable, as they may reveal numerous high-potential stocks. The following article will discuss the smart money sentiment towards AnaptysBio, Inc. (NASDAQ:ANAB).
Were Hedge Funds Right About Merit Medical Systems, Inc. (MMSI)?
Is Merit Medical Systems, Inc. (NASDAQ:MMSI) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. The top picks of these firms have historically outperformed the market when we account for known risk factors, making them very valuable investment ideas.
Merit Medical Systems, Inc. (NASDAQ:MMSI) was in 18 hedge funds’ portfolios at the end of the first quarter of 2021. The all time high for this statistic is 20. MMSI investors should be aware of a decrease in hedge fund sentiment in recent months. There were 20 hedge funds in our database with MMSI positions at the end of the fourth quarter. Our calculations also showed that MMSI isn’t among the 30 most popular sto